| Product Code: ETC9931721 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Specimen, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
3.9 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.3 Rising prevalence of rare diseases in the region |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of rare biomarkers and their importance |
4.3.2 Stringent regulatory requirements for specimen collection and storage in the UAE |
4.3.3 High costs associated with rare biomarkers specimen collection and stabilization technologies |
5 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Trends |
6 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market, By Types |
6.1 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Cell Free DNA (ccfDNA), 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Exosomes/Extracellular Vesicles, 2021- 2031F |
6.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Isolation Kits and Reagents, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Blood Collection Tubes, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Systems, 2021- 2031F |
6.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market, By Specimen |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Serum/Plasma, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market, By Nucleic Acid and other Biomolecules |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By RNA, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By DNA, 2021- 2031F |
6.4.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By NIPT, 2021- 2031F |
6.5.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transcriptomics, 2021- 2031F |
6.5.5 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.5.6 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transplant Rejection, 2021- 2031F |
6.5.7 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Population Screening, 2021- 2031F |
6.5.8 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Perinatal Clinics, 2021- 2031F |
6.6.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Public Health Labs, 2021- 2031F |
6.6.5 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Private or Commercial Labs, 2021- 2031F |
6.6.6 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Physician Labs, 2021- 2031F |
6.6.7 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Imports from Major Countries |
8 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Key Performance Indicators |
8.1 Number of research collaborations between local healthcare institutions and international rare biomarkers companies |
8.2 Adoption rate of advanced specimen collection and stabilization technologies in healthcare facilities |
8.3 Percentage increase in the diagnosis and treatment of rare diseases using biomarkers in the UAE |
9 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Specimen, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
9.5 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Rare Biomarkers Specimen Collection and Stabilization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here